rethinkPeptides Search
Menu
Study breakdown

Ghrelin Receptor Inverse Agonists: Blocking the Always-On Receptor for Obesity Treatment

evidence
The takeaway

The ghrelin receptor's constitutive activity (always partially active) can be blocked by inverse agonists, which reduce the receptor's baseline signaling — a more effective obesity strategy than simple antagonism.

Key finding

The ghrelin receptor's constitutive activity (always partially active) can be blocked by inverse agonists, which reduce the receptor's baseline signal

What the researchers found

The ghrelin receptor's constitutive activity (always partially active) can be blocked by inverse agonists, which reduce the receptor's baseline signaling — a more effective obesity strategy than simple antagonism.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2010.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Ghrelin Receptor Inverse Agonists: Blocking the Always-On Receptor for Obesity Treatment
What was found?
The ghrelin receptor's constitutive activity (always partially active) can be blocked by inverse agonists, which reduce the receptor's baseline signaling — a more effective obesity strategy than simple antagonism.

Read the original research

Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.

Methods in enzymology, 485, 103-21

Citation

Els, Sylvia; Beck-Sickinger, Annette G; Chollet, Constance. (2010). Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.. Methods in enzymology, 485, 103-21. https://doi.org/10.1016/B978-0-12-381296-4.00006-3